US 2022/0175809 A1Published application

Treatment and prevention of infections by herpesviridae with delphinidin-3-glucoside

AssigneeEvonik Operations GmbH

InventorsJean-Luc HERBEAUX, Norbert WINDHAB, Christoph BRÜCHER, Anne BENEDIKT, Andrea ENGEL, Maria STEINKE, Jochen BODEM

Life of this patent

Estimating the term…

Abstract

The present invention is related to Delphinidin-3-glucoside (D3G) for use in treating or preventing a vims infection in a subject, wherein the virus is from the Herpesviridae family.

Claims21

Dependent claims

A method for treating a virus infection, the method comprising:

administering Delphinidin-3-glucoside (D3G) to a subject in need thereof, wherein the virus infection is caused by a virus of the Herpesviridae family.

Dependencies are inferred from the claim text.

Facts

Application: 17/598,557Filed 27 Mar 2020
Priority: EP 19166083.629 Mar 2019
Published: 9 Jun 2022
Term ends: Not estimatedThe source records don’t support an estimate.

Classification22 codes

A61K 31/352
Having six-membered rings with one oxygen as the only ring hetero atom: condensed with carbocyclic rings, e.g. methantheline
A61K 31/517
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim: ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
A61K 31/52
Ortho- or peri-condensed with heterocyclic rings: purines, e.g. adenine
A61K 31/522
Purines, e.g. adenine: having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir

Family

No related US applications are recorded in the indexed filing history.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results